ERBB2 and breast cancer: Dietary flavonoid hesperetin reduces the development of MDA‐MB‐231 BC cells by inhibiting the activity of HER2 Tyrosine Kinase (HER2‐TK), causing MMP loss, chromatin condensation, and activating caspase‐8 and‐3, which causes cell cycle arrest at the G2 phase.232